Literature DB >> 21594670

Serum 25-hydroxyvitamin D status in hip and spine-fracture patients in Japan.

Mayumi Sakuma1, Naoto Endo, Hiroshi Hagino, Atsushi Harada, Yasumoto Matsui, Tetsuo Nakano, Kozo Nakamura.   

Abstract

BACKGROUND: Serum 25-hydroxyvitamin D (25(OH)D) is used as an index that reflects the level of vitamin D. We have previously reported, on the basis of a study in Sado in Niigata, that patients with hip fracture have lower serum 25(OH)D levels than non-hip-fracture cases. In this study, the serum 25(OH)D status in hip-fracture cases was examined in four regions in Japan. Although most hip-fracture patients have experienced past spine-compression fractures, the relationship of these fractures and 25(OH)D is unknown. Therefore, we also examined the 25(OH)D level in spine-compression fracture patients in the same locations and time periods.
METHODS: The levels of 25(OH)D, intact parathyroid hormone (intact PTH), undercarboxylated osteocalcin (ucOC), urine N-terminal crosslinking telopeptide of type I collagen (NTX), and bone mineral density were examined in patients with hip and spine fracture due to osteoporosis in several regions in Japan.
RESULTS: There were no significant differences in age, BMI, serum 25(OH)D, serum intact PTH, and serum ucOC among the regions. Levels of serum 25(OH)D were low in patients with hip fracture and spine fracture. The average serum 25(OH)D level was significantly lower in hip-fracture patients than in spine-fracture patients (16.3 vs. 18.1 ng/mL, P < 0.05). High serum ucOC was found in 37% of hip-fracture patients and 44% of spine-fracture patients.
CONCLUSIONS: Both hip and spine-fracture patients have vitamin D insufficiency, with similar results found in elderly patients in four areas of Japan. The severity of this condition tends to be more serious in hip-fracture patients than in spine-fracture patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21594670     DOI: 10.1007/s00776-011-0089-4

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  10 in total

1.  Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-regulation.

Authors:  Wu Hao; Syoichi Tashiro; Tomoka Hasegawa; Yuiko Sato; Tami Kobayashi; Toshimi Tando; Eri Katsuyama; Atsuhiro Fujie; Ryuichi Watanabe; Mayu Morita; Kana Miyamoto; Hideo Morioka; Masaya Nakamura; Morio Matsumoto; Norio Amizuka; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  J Biol Chem       Date:  2015-05-21       Impact factor: 5.157

2.  Assessment criteria for vitamin D deficiency/insufficiency in Japan: proposal by an expert panel supported by the Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society [Opinion].

Authors:  Ryo Okazaki; Keiichi Ozono; Seiji Fukumoto; Daisuke Inoue; Mika Yamauchi; Masanori Minagawa; Toshimi Michigami; Yasuhiro Takeuchi; Toshio Matsumoto; Toshitsugu Sugimoto
Journal:  J Bone Miner Metab       Date:  2016-11-23       Impact factor: 2.626

3.  Incidence of hip fracture in Niigata, Japan in 2004 and 2010 and the long-term trends from 1985 to 2010.

Authors:  Dai Miyasaka; Naoto Endo; Einosuke Endo; Mayumi Sakuma; Noriaki Yamamoto; Naohito Tanabe; Norio Imai; Ken Suda
Journal:  J Bone Miner Metab       Date:  2015-03-16       Impact factor: 2.626

4.  Bilateral fragility femoral supracondylar fractures in adolescents due to long-term home stay during the COVID-19 pandemic: A case report.

Authors:  Hyonmin Choe; Naomi Kobayashi; Masatoshi Oba; Taro Tezuka; Hiroyuki Ike; Akira Morita; Koki Abe; Yutaka Inaba
Journal:  J Orthop Sci       Date:  2022-06-08       Impact factor: 1.805

5.  A decrease in the number and incidence of osteoporotic hip fractures among elderly individuals in Niigata, Japan, from 2010 to 2015.

Authors:  Norio Imai; Naoto Endo; Yugo Shobugawa; Shinya Ibuchi; Hayato Suzuki; Dai Miyasaka; Mayumi Sakuma
Journal:  J Bone Miner Metab       Date:  2017-09-07       Impact factor: 2.626

6.  Comparison of the effects of eldecalcitol with either raloxifene or bisphosphonate on serum tartrate resistant acid phosphatase-5b, a bone resorption marker, in postmenopausal osteoporosis.

Authors:  Junichi Takada; Satoshi Ikeda; Tetsuya Kusanagi; Satoshi Mizuno; Hiroshi Wada; Kousuke Iba; Takashi Yoshizaki; Toshihiko Yamashita
Journal:  Clin Cases Miner Bone Metab       Date:  2016-05-11

7.  The vitamin D analogue ED71 but Not 1,25(OH)2D3 targets HIF1α protein in osteoclasts.

Authors:  Yuiko Sato; Yoshiteru Miyauchi; Shigeyuki Yoshida; Mayu Morita; Tami Kobayashi; Hiroya Kanagawa; Eri Katsuyama; Atsuhiro Fujie; Wu Hao; Toshimi Tando; Ryuichi Watanabe; Kana Miyamoto; Hideo Morioka; Morio Matsumoto; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

8.  Vitamin D deficiency in adult fracture patients: prevalence and risk factors.

Authors:  E A Gorter; P Krijnen; I B Schipper
Journal:  Eur J Trauma Emerg Surg       Date:  2015-07-21       Impact factor: 3.693

9.  Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis.

Authors:  Hiroshi Hagino; Toshiyuki Takano; Masao Fukunaga; Masataka Shiraki; Toshitaka Nakamura; Toshio Matsumoto
Journal:  J Bone Miner Metab       Date:  2012-11-06       Impact factor: 2.626

Review 10.  The role of vitamin D and vitamin D deficiency in orthopaedics and traumatology-a narrative overview of the literature.

Authors:  Gerrit S Maier; Manuel Weissenberger; Maximilian Rudert; Klaus E Roth; Konstantin Horas
Journal:  Ann Transl Med       Date:  2021-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.